Dermatology Best Practice: Getting Beneath the Surface in Atopic Dermatitis: A Patient-Centered Approach to Optimize Outcomes

In order to request this CME/CE activity for your center, please contact Marissa Silvestri at cme@permedical.com.

Getting Beneath the Surface in Atopic Dermatitis: A Patient-Centered Approach to Optimize Outcomes

November 2017 – June 2018

Overview: Given the range of skills required to successfully manage and cope with atopic dermatitis (AD), multidisciplinary interventions have been developed to transfer necessary knowledge and tools to patients, with the aim of improving outcomes such as disease control, adherence, and quality of life. We review the evidence for different approaches to multidisciplinary interventions in atopic dermatitis for adults with severe AD and emphasize the common elements of successful programs. This activity will serve to educate healthcare professionals on the emergence of new agents and clinical data within the therapeutic area. Continuing education will improve the clinicians’ knowledge of AD and its treatment, allowing for appropriate use of medication, improved patient-centered communication and adherence, and enhanced health-related quality of life. Due to the complexities of the disease, a multidisciplinary, patient-centered management approach is ideal for the patient with AD.

Target Audience: This activity is directed toward community dermatologists, allergists, immunologists, rheumatologists and primary care physicians. Fellows, nurse practitioners, physician assistants, researchers, and other healthcare professionals interested in the treatment or management of atopic dermatitis are also invited to participate.

Learning Objectives

• List the scientific advances and improvements in our understanding the pathoimmunobiology of atopic dermatitis
• Articulate the results of landmark clinical trials in atopic dermatitis in patients with moderate-to severe disease
• Individualize treatment plans for adults with moderate-to-severe AD based on current guideline recommendations for AD
• Explain how a multidisciplinary approach to care may improve patient outcomes in AD
• Describe how to engage patients in shared-decision making in regards to their AD treatment options to improve

Global Contact Information

For information about the approval of this program, please contact Global at 303-395-1782 or cme@globaleducationgroup.com.

Instructions to Receive Credit

In order to receive credit for this activity, the participant must obtain a score of 70% or better on the post-test. This activity is offered at no cost to participants. Please complete the post-test and evaluation. You will receive a digital copy of your credit certificate. Your online certificate will be saved on myCME within your Profile/CME History, which you can access at any time.

Fee Information & Refund/Cancellation Policy

There is no fee for this educational activity.

Disclosure of Conflicts of Interest

Global Education Group (Global) requires instructors, planners, managers and other individuals and their spouse/life partner who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by Global for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations.

The planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

Name of Planner or Manager	Reported Financial Relationship
Ashley Marostica, RN, MSN	Nothing to disclose
Kristen Delisi, NP	Nothing to disclose
Lindsay Borvansky	Nothing to disclose
Karen Kaufman	Nothing to disclose
Andrea Funk	Nothing to disclose
Liddy Knight	Nothing to disclose
David Heckard	Nothing to disclose
Maryjo Dixon, RPh	Nothing to disclose
Kathleen Bowen	Nothing to disclose

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Global Education Group (Global) and PER® do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.